Jushi Holdings (JUSHF) Revenue Growth (1y) (2022 - 2026)
Jushi Holdings (JUSHF) Revenue Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -0.81% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -0.24% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.07% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.92% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 4.88% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 39.49% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 10.23% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 9.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.61% |
| Mar 31, 2026 | 4.05% |
| Dec 31, 2025 | 3.76% |
| Sep 30, 2025 | 6.60% |
| Jun 30, 2025 | 0.70% |
| Mar 31, 2025 | -2.46% |
| Dec 31, 2024 | -2.82% |
| Sep 30, 2024 | -5.76% |
| Jun 30, 2024 | -2.75% |
| Mar 31, 2024 | -6.32% |
| Dec 31, 2023 | -11.78% |
| Sep 30, 2023 | -10.22% |
| Jun 30, 2023 | -8.70% |
| Mar 31, 2023 | 12.90% |
| Dec 31, 2022 | 16.59% |
| Sep 30, 2022 | 34.89% |
| Jun 30, 2022 | 52.39% |